Episode 434: IMPACT Series - A Walk Through the History of VEGF TKI Development in RCC

Danny Heng, Head of Medical Oncology at the Arthur J.E. Child Comprehensive Cancer Centre, joins to tour through VEGF TKI drug development from sorafenib to tivozanib and everything in between.